Applied Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
09/05/2024 19:23
* Applied Therapeutics Inc APLT.OQ reported a quarterly
adjusted
loss of 67 cents per share for the quarter ended in March,
lower than the same quarter last year, when the company reported
EPS of -18 cents. The mean expectation of four analysts for the
quarter was for a loss of 16 cents per share. Wall Street
expected results to range from -22 cents to -7 cents per share.
* Reported revenue was zero; analysts expected $3.33
million.
* Applied Therapeutics Inc's reported EPS for the quarter
was a
loss of 67 cents.
* The company reported a quarterly loss of $83.94 million.
* Applied Therapeutics Inc shares had fallen by 30.7% this
quarter and gained 40.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 31.3%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"
Wall Street's median 12-month price target for Applied
Therapeutics Inc is $13.00
This summary was machine generated from LSEG data May 9 at 06:22
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.16 -0.67 Missed
Dec. 31 2023 -0.23 -0.34 Missed
Sep. 30 2023 -0.26 -0.47 Missed
Jun. 30 2023 -0.26 -0.37 Missed